Abstract
No public abstract is available from the verified source records.
Yunkai Wang, Yeshun Wu, Hanzhong Zhang, Wenbing Jiang, Jingyong Huang
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Atherosclerosis reviewed
10.14744/anatoljcardiol.2024.8 · 2024
Targeting atherosclerosis beyond cholesterol reduction
10.1038/s44161-025-00662-w · 2025
Editorial: therapeutic strategies to lower residual dyslipidemic CV risk beyond LDL-C and statins
10.3389/fcvm.2025.1597062 · 2025
Vascular senescence and aging: mechanisms, clinical implications, and therapeutic prospects
10.1007/s10522-025-10256-5 · 2025
The role of cell junctions in atherosclerosis: implications for inflammation, endothelial dysfunction, and plaque stability
10.1007/s13105-025-01106-6 · 2025
Wnt signaling cascades and their role in coronary artery health and disease
2021
Long non-coding RNAs at the crossroad of vascular smooth muscle cell phenotypic modulation in atherosclerosis and neointimal formation
10.1016/j.atherosclerosis.2022.11.021 · 2023
Therapeutic implications of NLRP3-mediated inflammation in coronary artery disease
10.1097/crd.0000000000000391 · 2022
Chemerin in atherosclerosis
10.1016/j.cca.2021.05.015 · 2021
Chemerin in atherosclerosis
10.1016/j.cca.2021.05.015 · 2021
Chemerin in atherosclerosis
10.1016/j.cca.2021.05.015 · 2021
Modulating the phenotypic transition of vascular smooth muscle cells via LKB1, a new pharmacologic target to strike atherosclerosis?
10.1016/j.ijcard.2023.131427 · 2024
Vascular biology and medicine: amyloid-beta alterations in neurocardiovascular diseases and new targets to treat smooth muscle cell dysfunction
10.1093/eurheartj/ehae878 · 2025
Stress, vascular smooth muscle cell phenotype and atherosclerosis: novel insight into smooth muscle cell phenotypic transition in atherosclerosis
10.1007/s11883-024-01220-8 · 2024
PCSK9 in Familial Hypercholesterolemia and Beyond
10.1001/jamacardio.2025.1408 · 2025
Colchicine for the primary prevention of cardiovascular events
2025
PCSK9 antibody-based treatment strategies for patients with statin intolerance
10.21873/invivo.12232 · 2021
Wnt/β-catenin and notch signaling pathways in cardiovascular disease: Mechanisms and therapeutics approaches
10.1016/j.phrs.2024.107565 · 2025
Anti-inflammatory mechanisms of the vascular smooth muscle PPARγ
10.1540/jsmr.57.1 · 2021
Editorial: mechanotransduction in vascular development and disease
10.3389/fphys.2024.1525184 · 2024
Wnt signaling pathway and sclerostin in the development of atherosclerosis and vascular calcification
10.17219/acem/169567 · 2024
Oil Red O and hematoxylin and eosin staining for quantification of atherosclerosis burden in mouse aorta and aortic root
10.1007/978-1-4939-2929-0_5 · 2015
Evaluation of Plaque Burden and Lipid Content in Atherosclerotic Plaques
10.1007/978-1-0716-1924-7_29 · 2022
Endothelial-to-mesenchymal transition contributes to accelerated atherosclerosis in Hutchinson-Gilford progeria syndrome
10.1161/circulationaha.123.065768 · 2024
Isolation and Analysis of Aortic Arch and Root Lesions in an Atherosclerotic Mouse Model
10.3791/67875 · 2025
Analysis of gene expression using lacZ reporter mouse lines
10.1007/978-1-0716-1008-4_2 · 2021
Protocol for whole-mount X-gal staining combined with tissue clearing in embryo and adult mouse using CUBIC
10.1016/j.xpro.2022.101127 · 2022
Protocol to visualize CD11c+ cells in atherosclerosis using LacZ reporter mice
10.1016/j.xpro.2022.101645 · 2022
A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
10.1038/s41587-020-00748-9 · 2021
Benchmarking UMI-based single-cell RNA-seq preprocessing workflows
10.1186/s13059-021-02552-3 · 2021
No additional external references are available.